713 related articles for article (PubMed ID: 35930484)
1. A Review of Respiratory Post-Acute Sequelae of COVID-19 (PASC) and the Potential Benefits of Pulmonary Rehabilitation.
Simon M; Simmons JE
R I Med J (2013); 2022 Sep; 105(7):11-15. PubMed ID: 35930484
[TBL] [Abstract][Full Text] [Related]
2. Effects of pulmonary rehabilitation on functional and psychological parameters in post-acute sequelae of SARS-CoV-2 infection (PASC) patients.
Nasrullah A; Virk S; Javed A; Shah A; Ramanujam D; Sharma A; Gutierrez L; Nauer K; Maggio M; Yin Y; Bajwa Y; Cheema T; Disilvio B
BMC Pulm Med; 2024 May; 24(1):231. PubMed ID: 38745298
[TBL] [Abstract][Full Text] [Related]
3. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.
Moghimi N; Di Napoli M; Biller J; Siegler JE; Shekhar R; McCullough LD; Harkins MS; Hong E; Alaouieh DA; Mansueto G; Divani AA
Curr Neurol Neurosci Rep; 2021 Jun; 21(9):44. PubMed ID: 34181102
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
[TBL] [Abstract][Full Text] [Related]
5. Neurological post-acute sequelae of SARS-CoV-2 infection.
Takao M; Ohira M
Psychiatry Clin Neurosci; 2023 Feb; 77(2):72-83. PubMed ID: 36148558
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC).
Sherif ZA; Gomez CR; Connors TJ; Henrich TJ; Reeves WB;
Elife; 2023 Mar; 12():. PubMed ID: 36947108
[TBL] [Abstract][Full Text] [Related]
7. Chronic Disease Self-Management of Post-Acute Sequelae of COVID-19 Among Older Adults: A Mixed-Methods Analysis.
Thomas-Purcell K; Davenport R; Ayala V; Purcell D; Ownby RL
Clin Interv Aging; 2023; 18():607-617. PubMed ID: 37082741
[TBL] [Abstract][Full Text] [Related]
8. Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection.
Hanson BA; Visvabharathy L; Orban ZS; Jimenez M; Batra A; Liotta EM; DeLisle RK; Klausner JD; Cohen P; Padhye AS; Tachas G; Koralnik IJ
Brain Behav Immun; 2023 Nov; 114():462-474. PubMed ID: 37704012
[TBL] [Abstract][Full Text] [Related]
9. Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC).
Mohandas S; Jagannathan P; Henrich TJ; Sherif ZA; Bime C; Quinlan E; Portman MA; Gennaro M; Rehman J;
Elife; 2023 May; 12():. PubMed ID: 37233729
[TBL] [Abstract][Full Text] [Related]
10. Long COVID in pediatrics-epidemiology, diagnosis, and management.
Toepfner N; Brinkmann F; Augustin S; Stojanov S; Behrends U
Eur J Pediatr; 2024 Apr; 183(4):1543-1553. PubMed ID: 38279014
[TBL] [Abstract][Full Text] [Related]
11. RECOVER-NEURO: study protocol for a multi-center, multi-arm, phase 2, randomized, active comparator trial evaluating three interventions for cognitive dysfunction in post-acute sequelae of SARS-CoV-2 infection (PASC).
Knopman DS; Laskowitz DT; Koltai DC; Charvet LE; Becker JH; Federman AD; Wisnivesky J; Mahncke H; Van Vleet TM; Bateman L; Kim DY; O'Steen A; James M; Silverstein A; Lokhnygina Y; Rich J; Feger BJ; Zimmerman KO
Trials; 2024 May; 25(1):326. PubMed ID: 38755688
[TBL] [Abstract][Full Text] [Related]
12. Tissue injury and leukocyte changes in post-acute sequelae of SARS-CoV-2: review of 2833 post-acute patient outcomes per immune dysregulation and microbial translocation in long COVID.
Islam MS; Wang Z; Abdel-Mohsen M; Chen X; Montaner LJ
J Leukoc Biol; 2023 Mar; 113(3):236-254. PubMed ID: 36807444
[TBL] [Abstract][Full Text] [Related]
13. Risk of post-acute sequelae of SARS-CoV-2 infection associated with pre-coronavirus disease obstructive sleep apnea diagnoses: an electronic health record-based analysis from the RECOVER initiative.
L Mandel H; Colleen G; Abedian S; Ammar N; Charles Bailey L; Bennett TD; Daniel Brannock M; Brosnahan SB; Chen Y; Chute CG; Divers J; Evans MD; Haendel M; Hall MA; Hirabayashi K; Hornig M; Katz SD; Krieger AC; Loomba J; Lorman V; Mazzotti DR; McMurry J; Moffitt RA; Pajor NM; Pfaff E; Radwell J; Razzaghi H; Redline S; Seibert E; Sekar A; Sharma S; Thaweethai T; Weiner MG; Jae Yoo Y; Zhou A; Thorpe LE
Sleep; 2023 Sep; 46(9):. PubMed ID: 37166330
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive brain stimulation for fatigue in post-acute sequelae of SARS-CoV-2 (PASC).
Santana K; França E; Sato J; Silva A; Queiroz M; de Farias J; Rodrigues D; Souza I; Ribeiro V; Caparelli-Dáquer E; Teixeira AL; Charvet L; Datta A; Bikson M; Andrade S
Brain Stimul; 2023; 16(1):100-107. PubMed ID: 36693536
[TBL] [Abstract][Full Text] [Related]
15. Early immune factors associated with the development of post-acute sequelae of SARS-CoV-2 infection in hospitalized and non-hospitalized individuals.
Leung JM; Wu MJ; Kheradpour P; Chen C; Drake KA; Tong G; Ridaura VK; Zisser HC; Conrad WA; Hudson N; Allen J; Welberry C; Parsy-Kowalska C; Macdonald I; Tapson VF; Moy JN; deFilippi CR; Rosas IO; Basit M; Krishnan JA; Parthasarathy S; Prabhakar BS; Salvatore M; Kim CC
Front Immunol; 2024; 15():1348041. PubMed ID: 38318183
[TBL] [Abstract][Full Text] [Related]
16. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin.
Pretorius E; Vlok M; Venter C; Bezuidenhout JA; Laubscher GJ; Steenkamp J; Kell DB
Cardiovasc Diabetol; 2021 Aug; 20(1):172. PubMed ID: 34425843
[TBL] [Abstract][Full Text] [Related]
17. Postacute Sequelae of SARS-CoV-2: Musculoskeletal Conditions and Pain.
Copley M; Kozminski B; Gentile N; Geyer R; Friedly J
Phys Med Rehabil Clin N Am; 2023 Aug; 34(3):585-605. PubMed ID: 37419534
[TBL] [Abstract][Full Text] [Related]
18. Considerations in Children and Adolescents Related to Coronavirus Disease 2019 (COVID-19).
Chen EY; Burton JM; Johnston A; Morrow AK; Yonts AB; Malone LA
Phys Med Rehabil Clin N Am; 2023 Aug; 34(3):643-655. PubMed ID: 37419537
[TBL] [Abstract][Full Text] [Related]
19. Low-dose naltrexone use for the management of post-acute sequelae of COVID-19.
Bonilla H; Tian L; Marconi VC; Shafer R; McComsey GA; Miglis M; Yang P; Bonilla A; Eggert L; Geng LN
Int Immunopharmacol; 2023 Nov; 124(Pt B):110966. PubMed ID: 37804660
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC).
Pretorius E; Venter C; Laubscher GJ; Kotze MJ; Oladejo SO; Watson LR; Rajaratnam K; Watson BW; Kell DB
Cardiovasc Diabetol; 2022 Aug; 21(1):148. PubMed ID: 35933347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
